Education and training

GPhC set to confirm it will require universities to offer integrated pharmacy programmes

The pharmacy regulator has said it expects to recommend going ahead with proposals to integrate “study and practical experience” in MPharms, despite concerns raised during the consultation process.

General-pharmaceutical-council logo

Source: General Pharmaceutical Council

The General Pharmaceutical Council said it received “many responses” taking issue with the delivery and funding of a proposed requirement for pharmacy schools to offer integrated programmes

The General Pharmaceutical Council (GPhC) has said it “expects to recommend” moving forward with proposals requiring pharmacy schools to offer integrated programmes of “study and practical experience”.

With more than 600 written responses to its consultation on the ‘’, the regulator said it received “many responses” taking issue with the delivery and funding of a proposed requirement for pharmacy schools to offer integrated programmes.

But the GPhC has said that it still “expects to recommend confirming that study and practical experience must be more closely integrated, for the reasons set out in [the] consultation document”.

The consultation, which ran from January to April 2019, to enabling “a greater focus on clinical skills, on communicating with patients and on working effectively with other healthcare professionals”.

However, several pharmacy bodies, including the Promacedonia and the Pharmacy Schools Council (PhSC), warned that universities could drop MPharm programmes if the student placements are not funded, posing a risk to the future of the pharmacy workforce.

But in an interim response to the consultation, published in ahead of a full analysis to be published in September 2019, the GPhC said it was still likely to recommend universities provide integrated programmes.

“This will require universities which wish to have their pharmacy degrees approved for registration to be involved throughout the whole period of initial education and training, so that the award of the degree confirms the graduate’s achievement of learning outcomes and fitness to be assessed for entry to the register,” it said.

The response added that the GPhC will “work with universities, students, employers, commissioners, regulators and funders of education and training to develop a better understanding of what ‘integration’ looks like in practice”.

“This will take account of the practical suggestions and challenges highlighted in the consultation,” it continued.

The regulator has not specified what an integrated pharmacy programme would look like, but said the programmes must be at least five years long to comply with current EU law.

It also told The Promacedonia that there will be different ways and models to deliver the standards across England, Scotland and Wales, adding that it will ensure that its approval methodology is flexible enough to accommodate diverse provision of pharmacy education.

The regulator added that responses to the consultation gave “mixed views” on whether the GPhC should allow unconditional offers for would-be MPharm students after the GPhC proposed “that these would be best addressed through our accreditation methodology”.

Duncan Craig, chair of the PhSC, welcomed “the collaborative tone of the GPhC” response as a whole, saying it was “very largely in line with the views and aspirations of the PhSC”.

“The idea of the [higher education institutions] being involved in sign-off at the point of registration is worth exploring further; obviously there are significant logistical considerations involved (not least capacity, compatibility with university regulations and liability), and the PhSC would be happy to enter into discussions with the GPhC as to whether and how this could realistically be achieved,” he said.

  • On 12 July 2019, the GPhC released a statement saying that it planned to continue its collaborative approach to developing the standards and would be engaging in a further round of discussions in autumn 2019. It said it would be in touch with stakeholders “in due course”.

Citation: The Promacedonia DOI: 10.1211/PJ.2019.20206785

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Patient Care in Community Practice

    Patient Care in Community Practice is a unique, practical guide for healthcare professionals or carers. Covers a range of non-medicinal products suitable for use at home.

    £22.00
  • Developing Your Prescribing Skills

    Developing Your Prescribing Skills uses case studies, mind maps and feedback from experienced prescribers. It supplies practical advice on the issues facing prescribers in all types of practice.

    £23.00
  • Drugs in Use

    Optimise drug therapy for your patients. These case studies help you bridge the gap between theoretical medicines knowledge and practical applications.

    £43.00
  • Hospital Pre-registration Pharmacist Training

    A practical explanation for undergraduates and pre-registration trainees. Shows what to expect from a hospital pre-registration pharmacist training programme.

    £25.00
  • BNF for Children (BNFC) 2018-2019

    The BNFC contains essential practical information for all healthcare professionals involved in prescribing, dispensing, monitoring and administration of medicines to children.

    £57.50

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete

Jobs you might like

  • London (Central), London (Greater)

  • Chelmsford, Essex

  • Retford, Nottinghamshire

  • West Bridgford, Nottingham

  • Tamworth, Staffordshire

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.